Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016 Sep 06; 134(10):e156-78.

View in: PubMed

subject areas

Advisory Committees
Advisory Committees
American Heart Association
American Heart Association
Aspirin
Aspirin
Cardiology
Cardiology
Coronary Artery Disease
Coronary Artery Disease
Drug Administration Schedule
Drug Administration Schedule
Drug Therapy, Combination
Drug Therapy, Combination
Drug-Eluting Stents
Drug-Eluting Stents
Hemorrhage
Hemorrhage
Humans
Humans
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Practice Guidelines as Topic
Practice Guidelines as Topic
Purinergic P2Y Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Randomized Controlled Trials as Topic
Randomized Controlled Trials as Topic
Research Report
Research Report
Thrombosis
Thrombosis
Time Factors
Time Factors
United States
United States

authors with profiles

Usman Baber